Citius Pharmaceuticals Announces Results of 2026 Annual Meeting of Stockholders

On April 6, 2026, Citius Pharmaceuticals, Inc. held its 2026 Annual Meeting of Stockholders. During the meeting, shareholders voted on two key proposals. First, seven nominees were elected to the Board of Directors to serve a one-year term expiring at the 2027 annual meeting: Leonard Mazur, Myron Holubiak, Suren Dutia, Dr. Eugene Holuka, Dennis M. McGrath, Robert Smith, and Carol Webb. Second, stockholders ratified the appointment of Wolf & Company, P.C. as the company's independent registered public accounting firm for the fiscal year ending September 30, 2026. The ratification passed with 8,593,946 votes in favor. The filing primarily serves to report the results of these routine corporate governance matters and does not contain updates regarding the company's clinical pipeline or financial performance.